Clinical trial
Randomised Controlled Trial Comparing the Safety and EfficAcy of the Cocoon PFO Occluder Versus Amplatzer PFO ClosurE Device for Percutaneous Closure of Patent Foramen Ovale in Patients With a History of Stroke or Transient Ischemic Attack A Non-Profit, Single-blind, Investigator Driven Trial
NCT07380490 is registered in ClinicalTrials.gov with Giuseppe Tarantini as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Controlled Trial Comparing the Safety and EfficAcy of the Cocoon PFO Occluder Versus Amplatzer PFO ClosurE Device for Percutaneous Closure of Patent Foramen Ovale in Patients With a History of Stroke or Transient Ischemic Attack A Non-Profit, Single-blind, Investigator Driven Trial
- Lead sponsor
- Giuseppe Tarantini
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 24, 2026
- Completion date
- July 31, 2028
- Enrollment
- 1,260 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
patent foramen ovale, stroke, transient ischemic attack (tia)